CME/CE Activities | AHRQ Effective Health Care Program

CME/CE Activities

The CME/CE activities listed below are offered by different credit providers, each having unique requirements for earning a credit certificate or a certificate of participation. Please review their requirements carefully.
If you are engaged in educating clinicians, researchers, and other health professionals, please see the EHC Program Slide Library for presentation resources.
CME/CE activities are available for the following health conditions and methods areas:

Breathing Conditions

Noninvasive Positive-Pressure Ventilation for Acute Respiratory Failure: Comparative Effectiveness New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: September 2012 – September 2015.

Guidance for Informed and Shared Decision Making about Diagnostic Tools and Treatments for Obstructive Sleep Apnea

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: October 31, 2011 – October 31, 2013.

Comparative Effectiveness of Diagnosis and Treatment of Obstructive Sleep Apnea

Physician

Sponsor: Baylor College of Medicine. Term of approval: August 2011 – August 2014.

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis

Physician

Sponsor: Baylor College of Medicine. Term of approval: March 2011 – March 2014.

Cancer

A Case Study in Prostate Cancer Treatment: Utilizing Comparative Effectiveness Research for Patient-Centered Decisionmaking

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: August 31, 2012 – August 30, 2014.

Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Weighing the
Options

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: August 31, 2011 – August 30, 2013.

Comparative Effectiveness of Therapies for Reducing the Risk of Primary Breast Cancer: Guidance for Shared Decision Making

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: July 29, 2011 – July 28, 2013.

Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer

Physician

Sponsor: Baylor College of Medicine. Term of approval: November 2010 – November 2013.

Developmental Delays, ADHD, Autism

Interventions for Adolescents and Young Adults with Autism Spectrum Disorders

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: August 31, 2012 – August 30, 2014.

Treatment Options for Attention Deficit Hyperactivity Disorder

Physician

Sponsor: Baylor College of Medicine. Term of approval: June 2012 – June 2015.

Comparing Pharmacologic, Behavioral, and Psychosocial Interventions for Attention Deficit Hyperactivity Disorder in Children

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: January 31, 2012 – January 30, 2014.

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders

Physician

Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June 2014.

Diabetes

Methods for Insulin Delivery and Glucose Monitoring in Diabetes: A Summary of Comparative Effectiveness Review

Physician
Pharmacist
Nurse
Case Manager

Sponsor: PRIME®. Term of approval: August 31, 2012 – September 30, 2013.

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: September 2012 – September 2015.

Practical Application of Shared and Informed Treatment Decisions Based on Comparative Effectiveness Research: Addressing the Needs of Underserved Patients with Type 2 Diabetes Mellitus

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.

AHRQ's Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings

Physician
Pharmacist
Nurse
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: January 31, 2012 – September 30, 2013.

Comparing the Benefits and Risks of Oral Medications for Type 2 Diabetes: An Interactive, Case-Based Approach

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist
Dietician

Sponsor: PRIME®. Term of approval: January 31, 2012 – January 30, 2014.

Management of an Adult With Type 2 Diabetes With Antidiabetic Medications: A Case Scenario

Physician

Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June, 2014.

Comparing Medicines for Type 2 Diabetes

Physician

Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June, 2014.

Digestive System Conditions

Comparative Effectiveness of Management Strategies for Adults With Gastroesophageal Reflux Disease: An Update

Physician

Sponsor: Baylor College of Medicine;. Term of approval: May 2012 – May 2015.

Updates on the Comparative Effectiveness of Management Strategies for Adults with Gastroesophageal Reflux Disease

Physician
Pharmacist
Nurse
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: October 31, 2011 – October 31, 2013.

Genitourinary Conditions

Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness

Physician

Sponsor: Baylor College of Medicine. Term of approval: May 2012 – May 2015.

Nonsurgical Treatments for Urinary Incontinence in Adult Women: Improving Informed Decision-Making through Patient Education

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: April 30, 2012 – April 29, 2014.

Gynecology

Noncyclic Chronic Pelvic Pain Therapies for Women

Physician

Sponsor: Baylor College of Medicine. Term of approval: April 2012 – April 2015.

Clinical Applications of Comparative Effectiveness of Noncyclic Chronic Pelvic Pain Therapies for Women

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.

Heart and Blood Vessel Conditions

Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2012 – October 2015.

Evidence-Based Simulations in Practice: Treatment Strategies for Women with Coronary Artery Disease (CAD) New!

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: September 15, 2012 – September 14, 2014.

Venous Thromboembolism Prophylaxis in Orthopedic Surgery

Physician

Sponsor: Baylor College of Medicine. Term of approval: August 2012 – August 2015.

Comparative Effectiveness Research: Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: June 30, 2012 – June 29, 2014.

Dietary Supplements in Adults taking Cardiovascular Drugs: A Comparative Effectiveness Review

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: May 31, 2012 – May 30, 2014.

Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Physician

Sponsor: Baylor College of Medicine. Term of approval: May 2012 – May 2015.

Self-Measured Blood Pressure Monitoring

Physician

Sponsor: Baylor College of Medicine. Term of approval: February 2012 – February 2015.

ACEIs, ARBs, or DRI for Adults With Hypertension

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2011 – October 2014.

Updates on the Treatment of Essential Hypertension: A Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors

Physician
Pharmacist
Nurse
Nurse Practitioner
Case Manager

Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.

Updates on the Comparative Effectiveness of Renin-Angiotensin-Aldosterone System Therapies for Essential Hypertension: A Feedback-Based Learning Activity

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.

AHRQ's Comparative Effectiveness Research on Angiotensin-Directed Therapies for Stable Ischemic Heart Disease: Applying the Results in Practice

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: June 30, 2011 – June 29, 2013.

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease

Physician
Pharmacist
Nurse
Case Manager

Sponsor: PRIME®. Term of approval: May 31, 2011 – May 31, 2013.

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function

Physician

Sponsor: Baylor College of Medicine. Term of approval: July 2010 – July 2013.

Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function

Physician

Sponsor: Baylor College of Medicine. Term of approval: July 2010 – July 2013.

Comparative Effectiveness of In-Hospital Off-Label Use of Recombinant Factor VIIa vs. Usual Care

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2010 – October 2013.

Infectious Diseases and HIV/AIDs

Treatment for Hepatitis C Virus Infection in Adults: Comparative Effectiveness New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: November 2012 – November 2015.

Procalcitonin-Guided Antibiotic Therapy New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2012 – October 2015.

Clostridium difficile Infections: Diagnosis, Treatment, and Prevention

Physician

Sponsor: Baylor College of Medicine. Term of approval: December 2011 – December 2014.

Mental Health

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: April 2013 – April 2016.

Second-Generation Antidepressants for Treating Adult Depression—An Update New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: September 2012 – September 2015.

First- and Second-Generation Antipsychotics for Children and Young Adults New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: September 2012 – September 2015.

Summary of the Comparative Effectiveness Review on Off-label Use of Atypical Antipsychotics

Physician
Pharmacist
Nurse
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: June 30, 2012 – September 30, 2014.

Comparative Effectiveness Review of Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: July 31, 2012 – July 30, 2014.

Summary of Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant

Sponsor: PRIME®. Term of approval: July 31, 2012 – July 30, 2014.

Off-Label Use of Atypical Antipsychotics: An Update

Physician

Sponsor: Baylor College of Medicine. Term of approval: August 2012 – August 2015.

Updates on the Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: A Feedback-Based Learning Activity

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: June 30, 2012 – June 29, 2014.

Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults

Physician

Sponsor: Baylor College of Medicine;. Term of approval: March 2012 – March 2015.

Applying AHRQ's Comparative Effectiveness Research in Nonpharmacological Treatment of Depression and Discussion in Military Settings

Physician
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: November 30, 2011 – November 30, 2013.

Traumatic Brain Injury and Depression

Physician

Sponsor: Baylor College of Medicine. Term of approval: April 2011 – April 2014.

Muscle, Bone, and Joint Conditions

Drug Therapy for Rheumatoid Arthritis in Adults New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: November 2012 – November 2015.

Disease Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Physician

Sponsor: Baylor College of Medicine. Term of approval: August 2012 – August 2015.

Summary of AHRQ's Update to the Comparative Effectiveness Review of Treatment to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

Physician
Pharmacist
Nurse
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: June 15, 2012 – September 30, 2013.

Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations

Physician

Sponsor: Baylor College of Medicine. Term of approval: July 2012 – July 2015.

Summary of AHRQ's Comparative Effectiveness Review of Drug Therapy for Rheumatoid Arthritis in Adults

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: May 31, 2012 – September 30, 2013.

Treatment To Prevent Fractures in Men and Women With Low Bone Desity or Osteoporosis: An Update

Physician

Sponsor: Baylor College of Medicine. Term of approval: May 2012 – May 2015.

Preventing Fractures in Patients with Osteoporosis or Low Bone Density: A Review of the Evidence

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: April 30, 2012 – April 29, 2014.

Comparative Effectiveness and Safety of Analgesics for Osteoarthritis: A Panel Discussion With Applications to Practice

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: March 31, 2012 – March 31, 2014.

Analgesics for Osteoarthritis–An Update

Physician

Sponsor: Baylor College of Medicine. Term of approval: February 2012 – February 2015.

Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.

Physician
Pharmacist
Nurse
Medical Assistant
Case Manager

Sponsor: PRIME®. Term of approval: March 1, 2012 – September 30, 2013.

Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis

Physician
Pharmacist
Nurse
Medical Assistant

Sponsor: PRIME®. Term of approval: December 31, 2011 – December 31, 2013.

Comparative Effectiveness of Pain Management Interventions for Hip Fractures: A Feedback-Based Learning Activity

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: September 30, 2011 – September 30, 2013.

Pain Management Interventions for Hip Fracture

Physician

Sponsor: Baylor College of Medicine. Term of approval: June 2011 – June 2014.

Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2010 – October 2013.

Ophthalmologic Conditions

Comparisons of Medical, Laser, and Incisional Surgical Treatments for Open-Angle Glaucoma in Adults

Physician

Sponsor: Baylor College of Medicine. Term of approval: February 2013 – February 2016.

Pregnancy and Childbirth

Progestogens for Prevention of Preterm Birth New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: September 2012 – September 2015.

Renal Disease

Management of Chronic Kidney Disease Stages 1–3 New!

Physician

Sponsor: Baylor College of Medicine. Term of approval: October 2012 - October 2015.

Comparative Effectiveness Research: Screening, Monitoring, and Treatment in Early Chronic Kidney Disease

Physician
Pharmacist
Nurse
Nurse Practitioner
Medical Assistant
Case Manager
Health Education Specialist

Sponsor: PRIME®. Term of approval: March 1, 2012 through February 28, 2014.